In our case, we specifically showed that SMOC2 stimulated RCC cells to undergo EMT by decreasing E-cadherin expression, increasing fibronectin and αSMA expression, and developing pseudopodal extensions. Here, SMOC2 is linked to renal cell carcinoma.